Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Heart of Case Management Awards 2017
Genex recognizes its extraordinary case management team through its 2017 Heart of Case Management Awards.
Honoring The Heart: 2017 Heart of Case Management Awards
Genex recognizes its extraordinary case management team through its 2017 Heart of Case Management Awards WAYNE, PA - May 10, 2017 -
How to Save a Life
Telephonic Case Management Meet Beverley Brown, RN, CRRN, CCM Beverley Brown, RN, CRRN, CCM, has e
RIMS Review: Jim Harris on Analytics, AI, and The Crystal Ball
During our time at RIMS 2017, we had Workers’ Comp industry stakeholders participate in WorkCompWire’s “RIMS Review” series, focused on what to look for this year, and key takeaways from the conference! Here’s what Jim Harris, VP, Analytics & Reporting at Genex Services had to say:
Aging Workforce: The Next Frontier In Workers’ Comp
By Chikita Mann, MSA, RN, CCM
Aging Workforce: The Next Frontier In Workers Comp
In the article "Aging Workforce: The Next Frontier in Workers' Comp," Enlyte explores the challenges and opportunities presented by an aging workforce in the realm of workers' compensation. The piece emphasizes the importance of early intervention, tailored care plans, and proactive communication to effectively manage claims involving older workers. By addressing age-related factors and potential comorbidities, the article advocates for strategies that support successful recovery and return-to-work outcomes for this demographic.